Authors: Creutzig, U Berthold, F Boos, J Fleischhack, G Gadner, H Gnekow, A Graubner, U Henze, G Hermann, J Imbach, P Jurgens, H Kabisch, H Korholz, D Niemeyer, CM Reinhardt, D Reiter, A Ritter, J Spaar, HJ Zimmermann, M

Citation: U. Creutzig et al., Improved treatment results in children with AML: Results of study AML-BFM 93, KLIN PADIAT, 213(4), 2001, pp. 175-185

Authors: Gobel, U Schneider, DT Calaminus, G Jurgens, H Spaar, HJ Sternschulte, W Waag, K Harms, D

Citation: U. Gobel et al., Multimodal treatment of malignant sacrococcygeal germ cell tumors: A prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89, J CL ONCOL, 19(7), 2000, pp. 1943-1950

Authors: zur Stadt, U Harms, DO Schluter, S Jorch, N Spaar, HJ Nurnberger, W Volpel, S Gutjahr, P Schrappe, M Janka, G Kabisch, H

Citation: U. Zur Stadt et al., Minimal residual disease analysis in acute lymphoblastic leukemia of childhood after an induction therapy without asparaginase, KLIN PADIAT, 212(4), 2000, pp. 169-173

Authors: Kaspers, CJL Zwaan, CM Veerman, AJP Rots, MG Pieters, R Bucsky, P Domula, M Gobel, U Graf, N Havers, W Jorch, N Kabisch, K Spaar, HJ Ritter, J Creutzig, U

Citation: Cjl. Kaspers et al., Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study, KLIN PADIAT, 211(4), 1999, pp. 239-244

Authors: Graubner, UB Boos, J Creutzig, U Dorffel, W Lakomek, M Niemeyer, C Schrappe, M Spaar, HJ Belohradsky, BH

Citation: Ub. Graubner et al., Antiinfectious prophylaxis in pediatric oncology, KLIN PADIAT, 211(4), 1999, pp. 347-352